NANXIN LI,JENNIFER L. HARRIS,PETER MCNAMARA,FANGXIAN SUN
申请号：
PT12703670
公开号：
PT2670401E
申请日:
2012.02.02
申请国别(地区):
PT
年份:
2015
代理人:
摘要：
The invention provides methods for using compounds of Formula (I) for treating an EML4-ALK+ mediated condition such as EML4-ALK+ non-small cell lung cancer, and optionally resistant to crizotinib； wherein R1, R2, R3, R4, R5 and R6 are as defined above.
